Vijay Kotte

Chief Executive Officer (CEO) at GoHealth

Board

Since June 3, 2022

Age

47 years

Education

Holds a Bachelor's degree in Business Administration with a focus on Finance and Organizational Management from Emory University and an MBA from the Kellogg School of Management, Northwestern University.

Tenure

Joined GOCO as Chief Executive Officer on June 3, 2022 and serves on the Board of Directors.

Also at GoHealth

Brad Burd

Chief Legal Officer and Corporate Secretary

Brendan Shanahan

Chief Financial Officer (CFO)

Michael Hargis

Chief Operating Officer

About

The executive is a seasoned healthcare leader with over two decades of experience in developing innovative healthcare models and Medicare-focused platforms, and he currently serves as Chief Executive Officer at GOCO.

He holds a strong educational background with a Bachelor's degree in Business Administration from Emory University and an MBA from the Kellogg School of Management at Northwestern University, which underpins his strategic approach and leadership capabilities.

Since joining GOCO on June 3, 2022, he has led the company as CEO and a Board member, while his previous roles at R1 RCM Inc. and DaVita Medical Group have equipped him with extensive operational and strategic experience. At 47 years old, his diverse background continues to drive progress and innovation in the healthcare sector.

$GOCO Performance Under Vijay Kotte

Past Roles

Organization	Role	Date Range	Details
R1 RCM Inc. (Nasdaq: RCM)	Chief Solutions Officer and Executive Vice President, Strategy and Corporate Development	2019 to 2022	Oversaw physician-focused operations including growth, product development, and strategic initiatives
DaVita Medical Group	Chief Value Officer	2014 to 2019	Operated within one of the nation’s leading independent medical groups providing primary and specialist care
Various Financial and Operational Roles in the Healthcare Industry	Multiple roles in financial and operational capacities	N/A	Held various positions prior to his tenure at DaVita Medical Group

Fixed Compensation

Data from FY 2023

Component Name	Amount	Payment Schedule	Additional Details
Base Salary	$900,000	Annual	Fixed compensation based on skills, experience, role
Stock Awards - Non-Performance RSUs	$3,525,000	Vesting per grant schedule	Grant-date fair value calculated under FASB ASC Topic 718
Option Awards	$691,664	Vesting per grant schedule	Grant-date fair value of stock options per FASB ASC Topic 718
Non-Equity Incentive Plan Compensation	$0	N/A	No bonus awarded in 2023 due to negative discretion
401(k) Match	$9,173	Annual vesting over four years	Represents 50% match on employee contributions up to 4% of compensation
Life Insurance Premiums	$306	Annual	Premiums for life and AD&D insurance
Executive Health Care	$15,371	Annual	Cost of executive health benefits provided
Perquisites	$360	Annual	Cell phone allowance provided to executives

Performance Compensation

Data from FY 2023

Performance-Based RSUs

Aspect	Detail
Performance Metric	Adjusted EBITDA CAGR percentage
Evaluation Period	Comparison of 2022 reported Adjusted EBITDA to Calendar Year 2025 Adjusted EBITDA
Threshold/Target	0% to 200% of the target award
Vesting Schedule	Vests upon filing Form 10-K for FY ending December 31, 2025, subject to continued service
Grant Date	April 10, 2023
Grant Date Fair Value	$14.10 per share
Number of Shares	83,333 shares

Annual Bonus Plan

Aspect	Detail
Performance Metrics & Weights	Enrollments & Transfers (20%), Encompass Penetration (20%), Captive Cost Per Effectuated Policy (20%), Adjusted EBITDA (40%)
Performance Scale	Each metric rated from 0% to 200% of target
Outcome	No bonus awarded for 2023 as decided by the Compensation Committee
Conditions	Cash-based incentives with no associated grant date, grant date fair value, or vesting schedule